Sep 23, 2026 5 0
Uploaded by Stanford
Favorite
Share
More Options
17
Exosomal lncRNA SILC1 from bicalutamide-activated mesenchymal stem cells promotes prostate cancer survival and bicalutamide resistance via the miR-577/RHOA axis_Page 1

Open in WPS to view all 17 pages